In an exclusive announcement, former American football star Tom Brady shared heartwarming news about his beloved pet. Brady revealed that his current dog, Junie, is a clone of his late dog, Lua, who passed away in December 2023. Lua, a pit bull mix, was a treasured companion that Brady shared with his ex-wife, supermodel Gisele Bündchen, and their children. The retired quarterback disclosed this touching revelation on November 4, coinciding with an announcement from Colossal Biosciences, a biotech company that Brady has invested in and collaborated with to clone his cherished Lua.
:max_bytes(150000):strip_icc():format(jpeg)/Tom-Brady-Lua-new-dog-miami-110325-tout-9d26d582606441efb50a14659474abdc.jpg)
Colossal Biosciences, known for its groundbreaking work in cloning, acquired Viagen Pets and Equine on the same day as Brady’s revelation. Viagen is recognised for cloning pets for celebrities like Barbra Streisand and Paris Hilton, whose dogs were successfully cloned after various events. The company has exclusive access to cutting-edge technologies developed by the Roslin Institute of Edinburgh, renowned for the cloning of Dolly the Sheep in the late 1990s. Lua was cloned using blood collected before her passing, as stated in a press release from Colossal Biosciences and shared with PEOPLE, a leading publication on human interest stories.
Expressing his deep love for animals, Brady emphasised the significance of his furry companions in his family’s life. Through a simple blood draw of Lua before her demise, Brady worked with Colossal to clone his beloved pet, granting his family another chance to cherish Lua’s essence through Junie. The synergy between Colossal and Viagen’s technologies offers hope to families grieving the loss of their pets while aiding in the preservation of endangered species. Brady’s heartfelt tribute to Lua on Instagram symbolised the special bond they shared, with Junie now continuing Lua’s legacy in their family.
Apart from the high-profile pet cloning, Colossal Biosciences has garnered attention for its groundbreaking projects such as the dire wolf reproduction and the resurrection of extinct species like the dodo bird. Brady and Bündchen, who adopted Lua during their marriage, considered the pit bull mix an integral part of their family. Lua’s passing in 2023 left a void in their lives, which the cloning of Junie has now helped to fill. Brady’s Instagram tributes to Lua and the emotional posts shared by Bündchen exemplify the deep affection and loss experienced by the family, underscoring the importance of their furry companions in their lives.
The acquisition of Viagen by Colossal signifies a new chapter in the realm of pet cloning and biotechnology, with the potential to transform the dynamics of animal preservation and companionship. The collaboration between these companies represents a significant leap in the field of genetics and reproductive technology, offering hope to pet owners facing the loss of their beloved animals. The touching story of Tom Brady and his cloned dog, Junie, serves as a poignant reminder of the enduring bond between humans and their furry companions, showcasing the lengths to which individuals go to preserve the memories of their cherished pets.
The heartwarming narrative of Brady’s cloned pet Lua and the subsequent acquisition of Viagen Pets and Equine by Colossal highlight the intersection of technology and emotion in the realm of pet cloning. This development not only speaks to the advancements in genetic engineering but also to the profound connections individuals share with their animal companions. As the world witnesses the fusion of biotechnology and heartfelt stories like Brady’s, the future of pet cloning and animal preservation looks promising, offering solace to pet owners seeking to immortalise the memories of their beloved furry friends.